Overview Transcatheter Self-expandable Valve Implantation for the Treatment of Severe Native Aortic Regurgitation Status: Recruiting Trial end date: 2031-05-30 Target enrollment: Participant gender: Summary Prospective, multicenter, randomized trial. Phase: N/A Details Lead Sponsor: Nanjing First Hospital, Nanjing Medical University